跳至主要内容
临床试验/NCT01975025
NCT01975025已完成不适用

Hemodialysis Frequency and the Calcification Propensity of Serum

Insel Gruppe AG, University Hospital Bern2 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2014年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
17
试验地点
2
主要终点
Change from baseline calcification propensity of serum

研究概览

简要总结

The aim of this clinical research project is to test the hypothesis that daily dialysis has favorable effects on the calcification propensity of human serum, when determined by the investigators' newly developed in vitro serum test. The investigators' hypothesis is that shorter interdialytic intervals will result in an improved calcification propensity of serum. The determination of serum calcification has the potential to become a novel measure of dialysis quality in the future.

详细描述

Background

The serum calcification test has been established and validated by A. Pasch and coworkers, the expertise to perform the necessary statistical analyses is present in the investigator's department, all patient-related procedures necessary for this project are routinely performed in the investigator's department.

Objective

Does short daily hemodialysis strengthen the calcification-inhibitory forces inherent in hemodialysis patient sera, when compared to conventional three-times weekly hemodialysis?

Methods

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic hemodialysis >3 months
  • Anuria (<100ml urine per day)
  • Written informed consent
  • Exclusion Criteria
  • Citrate dialysis
  • Significant fistula recirculation (>15%)
  • Infection

排除标准

  • 未提供

结局指标

主要结局

Change from baseline calcification propensity of serum

时间窗: 6 weeks

次要结局

  • Change from baseline of sodium, potassium, calcium, phosphate, magnesium, albumin, protein, hematocrit and their correlation with calcification propensity of serum(6 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验